• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BLACKSWAN VASCULAR, INC. LAVA-18, 6 ML; Embolization Agent, Vascular

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BLACKSWAN VASCULAR, INC. LAVA-18, 6 ML; Embolization Agent, Vascular Back to Search Results
Model Number SLLES186
Medical Device Problem Code Failure to Transmit Record (1521)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 04/30/2025
Type of Reportable Event Malfunction
Event or Problem Description
Hospital staff followed directions by shaking lava for over 20 mins.The tech pulled up 2 one ml syringes of lava.The physician slowly injected dmso through a needle, as he was performing an endoleak procedure.The physician then injected one syringe of lava and could not visualize the lava under fluoroscopy.He then reached for a second syringe and slowly injected the lava.He stopped at about 0.5 ml since again he still could not visualize the lava.He finished the procedure by using a non sirtex/blackswan product.
 
Additional Manufacturer Narrative
A new review of this event was performed.A retrospective mdr has been filed out of an abundance of caution due to the potential for serious injury.The event did not involve death or serious injury.The patient was treated with a different device.The device labeling (ifu) states adequate fluoroscopic visualization must be maintained during lava delivery and to stop lava delivery if visualization is lost until adequate visualization is reestablished.Batch record review showed the device was manufactured to released specifications and had passing quality test results.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LAVA-18, 6 ML
Common Device Name
Embolization Agent, Vascular
Manufacturer (Section D)
BLACKSWAN VASCULAR, INC.
709 sandoval way
hayward CA 94544
Manufacturer Contact
melissa sanchez
709 sandoval way
hayward, MA 94544
MDR Report Key22668020
Report Number3009088444-2025-00001
Device Sequence Number14381634
Product Code QVG
UDI-Device Identifier00850055697027
UDI-Public(01)00850055697027(17)270817(10)10826
Combination Product (Y/N)N
Initial Reporter StateCA
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Initial Reporter Occupation Other
Type of Report Initial
Report Date (Section B) 07/30/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberSLLES186
Device Lot Number10826
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/02/2025
Initial Report FDA Received Date07/30/2025
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient SexUnknown
-
-